Why AnteoTech, Newcrest, Nitro, and ResMed shares are falling

These ASX shares are ending the week in the red…

| More on:
share price dropping

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In late trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with on a positive note. At the time of writing, the benchmark index is up 2.2% to 6,990.9 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are falling:

AnteoTech Ltd (ASX: ADO)

The AnteoTech share price has crashed 25% to 23.5 cents. This follows the release of an update on its EuGeni Reader and COVID-19 Rapid Diagnostic Test (RDT). According to the release, AnteoTech has received a request for further information from the Therapeutic Goods Administration (TGA). This relates to the collection of additional clinical data, together with other aspects of information. These delays could see AnteoTech miss out on the incredible demand for rapid antigen tests at present.

Newcrest Mining Ltd (ASX: NCM)

The Newcrest share price is down 6% to $21.64. Investors have been selling gold shares today following a pullback in the price of the precious metal. In addition, Newcrest released its second quarter update this morning which shows that it will need a very strong second half to achieve its guidance. Newcrest recorded half year gold production of 832.3koz, which compares to its FY 2022 guidance of 1,800koz to 2,000koz.

Nitro Software Ltd (ASX: NTO)

The Nitro share price is down 3.5% to $1.78. This is despite the document productivity company releasing a fourth quarter update which revealed that it achieved the low end of its guidance in FY 2021. Nitro delivered a 41% increase in Annual Recurring Revenue (ARR) to US$40.1 million over the 12 months. Investors appear to have been expecting stronger growth.

ResMed Inc. (ASX: RMD)

The ResMed share price is down 1% to $31.11 after its second quarter update fell a touch short of expectations. The sleep treatment company reported a 12% increase in revenue to US$894.9 million and a 12% lift in net income to US$201.8 million. Goldman Sachs notes that its revenue was 3% below consensus estimates due to weaker than expected device sales because of supply chain challenges.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Nitro Software Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

Group of entrepreneurs feeling frustrated during a meeting in the office. Focus is on man with headache.
Share Fallers

5 worst ASX All Ords shares of 2025, and why brokers rate 4 of them a buy

The ASX All Ords rose by 7.11% in 2025 but as always, there were losers in the pack.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Capstone Copper, Life360, Northern Star, and Weebit Nano shares are falling today

These shares are having an unhappy start to 2026.

Read more »

a man clasps his hand to his forehead as he looks down at his phone and grimaces with a pained expression on his face as he watches the Pilbara Minerals share price continue to fall
Share Fallers

These were the worst performing ASX 200 shares in 2025

Shareholders of these shares will be hoping for better in 2026.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why 4Medical, Guzman Y Gomez, Lynas, and Predictive Discovery shares are falling today

These shares are ending the year in the red. But why?

Read more »

A man in a suit and glasses guffaws at his computer screen in bewilderment.
Share Fallers

Shocking declines: Australian shares that disappointed investors in 2025

Big names, big losses. These Australian shares shocked investors with steep declines in 2025.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

Why Evolution Mining, FireFly, Unico Silver, and Weebit Nano shares are tumbling today

These shares are having a poor session on Tuesday. What's going on?

Read more »

Investor covering eyes in front of laptop
Share Fallers

Why are ASX silver stocks getting hammered today?

ASX silver stocks are closing out the final full trading day of 2025 with a whimper. But why?

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Share Fallers

Why Boss Energy, DroneShield, EOS, and Netwealth shares are falling today

These shares are starting the week in the red. But why?

Read more »